Skip to main content
. 2018 Jun 13;315(4):R619–R626. doi: 10.1152/ajpregu.00071.2018

Table 3.

Changes in fasting acylated ghrelin and GLP-1 concentrations of participants exercising to expend 1,500 or 3,000 kcal/wk for 12 wk

Baseline Week 12 Adjusted Difference (95% CI)
GLP-1, pM 59.2 ± 4.1 52.6 ± 3.5 −6.7 (−11.6, −1.8)*
Acylated ghrelin, pg/ml 842.6 ± 65.0 909.1 ± 64.3 66.5 (8.6, 124.4)*
Peptide-YY, pg/ml 202.8 ± 14.0 189.9 ± 14.1 −13.1 (−35.8, 9.7)*
Myostatin, mg/l 41.0 ± 1.4 42.3 ± 1.4 1.0 (−0.8, 2.7)
Irisin, µg/ml 9.0 ± 0.5 8.8 ± 0.6 −0.3 (−1.1, 0.43)
Insulin, mIU/l 9.0 ± 1.0 8.2 ± 0.9 −0.9 (−2.4, 0.69)
Glucose, mg/dl 94.5 ± 1.4 93.9 ± 1.4 −0.6 (−3.3, 2.0)

Values are means ± SE. GLP-1, glucagon-like peptide 1; CI, confidence interval.

*

Different from zero (P < 0.01).

HHS Vulnerability Disclosure